Amgen Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AMGN Nasdaq 2836 www.amgen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amgen Inc.

5 Safe High-Yield Stocks Boomers Should Own in August - Aug 15th, 2026 5:00 am
GLP-1 Demand Is Soaring. 2 Stocks That Could Benefit From This (Hint: Not Eli Lilly or Novo Nordisk) - Aug 14th, 2026 4:50 pm
BofA biotech scorecard: Two buys and odd one out - Aug 14th, 2026 11:07 am
Amgen (AMGN) Stock Looks Undervalued With A 37% Fair Value Gap - Aug 14th, 2026 6:09 am
Amgen (AMGN) Opens New Science And Innovation Center In Hyderabad - Aug 14th, 2026 5:12 am
How to Build $7,200 a Month in Dividend Income Without Selling a Single Share - Aug 13th, 2026 2:14 pm
Wave Life Sciences: A $1 Billion RNA-Medicine Bargain Ripe for Pharma Takeover - Aug 13th, 2026 7:05 am
Amgen’s Q2 Earnings Call: Our Top 5 Analyst Questions - Aug 13th, 2026 2:05 am
BeOne Medicines Ltd (ONC) (Q2 2026) Earnings Call Highlights: Revenue Surges 30% to $1. ... - Aug 12th, 2026 7:04 pm
Amgen Stock And The Price Of A Promise - Aug 12th, 2026 1:17 pm
AMGEN TO OPEN NEW SCIENCE & INNOVATION CENTER IN GENOME VALLEY, HYDERABAD - Aug 12th, 2026 2:25 am
Amgen (AMGN) Q2 2026 Earnings Call Transcript - Aug 11th, 2026 5:57 pm